Trader consensus on Polymarket reflects a 94% implied probability against Anthropic being acquired before 2027, driven by the company's aggressive expansion as an acquirer rather than a target. Just weeks ago, Anthropic completed its $400 million stock acquisition of biotech AI startup Coefficient Bio—its third such deal since December 2025, including Bun and Vercept—to bolster Claude model's capabilities in coding, agents, and drug discovery. A February $30 billion Series G funding round valued it at $380 billion post-money, with fresh investor offers this week pushing toward $800 billion, alongside IPO preparations targeting late 2026. These moves underscore strong independence amid booming enterprise adoption of Claude large language models, despite existing minority stakes from Amazon and Google. Realistic challenges include potential IPO delays from regulatory scrutiny or escalating AI compute costs prompting a strategic sale, though current momentum favors autonomy.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트$14,101 거래량
$14,101 거래량
2026.12.31
$14,101 거래량
$14,101 거래량
2026.12.31
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 94% implied probability against Anthropic being acquired before 2027, driven by the company's aggressive expansion as an acquirer rather than a target. Just weeks ago, Anthropic completed its $400 million stock acquisition of biotech AI startup Coefficient Bio—its third such deal since December 2025, including Bun and Vercept—to bolster Claude model's capabilities in coding, agents, and drug discovery. A February $30 billion Series G funding round valued it at $380 billion post-money, with fresh investor offers this week pushing toward $800 billion, alongside IPO preparations targeting late 2026. These moves underscore strong independence amid booming enterprise adoption of Claude large language models, despite existing minority stakes from Amazon and Google. Realistic challenges include potential IPO delays from regulatory scrutiny or escalating AI compute costs prompting a strategic sale, though current momentum favors autonomy.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
마켓 개설일: Nov 12, 2025, 5:14 PM ET
거래량
$14,101종료일
2026.12.31마켓 개설일
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects a 94% implied probability against Anthropic being acquired before 2027, driven by the company's aggressive expansion as an acquirer rather than a target. Just weeks ago, Anthropic completed its $400 million stock acquisition of biotech AI startup Coefficient Bio—its third such deal since December 2025, including Bun and Vercept—to bolster Claude model's capabilities in coding, agents, and drug discovery. A February $30 billion Series G funding round valued it at $380 billion post-money, with fresh investor offers this week pushing toward $800 billion, alongside IPO preparations targeting late 2026. These moves underscore strong independence amid booming enterprise adoption of Claude large language models, despite existing minority stakes from Amazon and Google. Realistic challenges include potential IPO delays from regulatory scrutiny or escalating AI compute costs prompting a strategic sale, though current momentum favors autonomy.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
거래량
$14,101종료일
2026.12.31마켓 개설일
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects a 94% implied probability against Anthropic being acquired before 2027, driven by the company's aggressive expansion as an acquirer rather than a target. Just weeks ago, Anthropic completed its $400 million stock acquisition of biotech AI startup Coefficient Bio—its third such deal since December 2025, including Bun and Vercept—to bolster Claude model's capabilities in coding, agents, and drug discovery. A February $30 billion Series G funding round valued it at $380 billion post-money, with fresh investor offers this week pushing toward $800 billion, alongside IPO preparations targeting late 2026. These moves underscore strong independence amid booming enterprise adoption of Claude large language models, despite existing minority stakes from Amazon and Google. Realistic challenges include potential IPO delays from regulatory scrutiny or escalating AI compute costs prompting a strategic sale, though current momentum favors autonomy.
Polymarket 데이터를 참조하는 실험적 AI 생성 요약입니다. 이것은 거래 조언이 아니며 이 마켓의 정산에 영향을 미치지 않습니다. · 업데이트
외부 링크에 주의하세요.
외부 링크에 주의하세요.
자주 묻는 질문